A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)

Not Applicable

Active, not recruiting

• Conditions: COPD; Asthma
• Interventions: Other: Benefits investigation

• Registration Number: NCT03927820
• Lead Sponsor: Vanderbilt University Medical Center

Brief Summary

The goal of this study is to assess the impact of pharmacist-led benefits investigations and application of clinical practice guidelines on patient access to inhalers and time to hospital readmission or Emergency Department (ED) visit.

Detailed Description

Not available

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study First Submitted: 2019-04-23
• Study First Submitted QC: 2019-04-23
• Study First Posted: 2019-04-25
• Study Start: 2019-09-09
• Status Verified: 2024-07
• Last Update Submitted: 2024-07-16
• Last Update Posted: 2024-07-17
• Primary Completion: 2025-06
• Study Completion: 2025-06

Recruitment & Eligibility

• Status: ACTIVE_NOT_RECRUITING
• Sex: All
• Target Recruitment: 914

Inclusion Criteria

• Adult patient admitted to Vanderbilt University Medical Center (VUMC) (excluding surgery services)
• on a long acting inhaler or prescribed a long acting inhaler during admission.

Read More

Exclusion Criteria

• Diagnosis of cystic fibrosis
• Diagnosis of graft versus host disease (GVHD)
• no medication insurance
• discharge to any post-acute care facility or inpatient hospice
• death during hospitalization

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Pharmacist Intervention	Benefits investigation	Patients randomized to the intervention arm received usual care plus inhaler review by study pharmacist who made recommendations for inhaler changes based on clinical guideline and insurance formulary compliance. Recommendations were sent to the patient's team for final approval prior to discharge.

Primary Outcome Measures

Name	Time	Method
Time to either hospital readmission or ER visit	6 months	Combined time (days) to either hospital readmission or emergency department visit after hospitalization (all outcomes measured at 6 months post-discharge with a 3 month interim analysis)

Secondary Outcome Measures

Name	Time	Method
frequency of prescribed inhaler at discharge	6 months	number of times the recommended inhaler was prescribed at discharge
frequency of hospital readmissions	6 months	number of hospital readmission 6 months post-discharge
frequency of short course prescription of oral steroid	6 months	number of oral steroid prescriptions in the 6 months post-discharge
Frequency of ED visit	6 months	number of ED visits 6 months post-discharge
time to 1st ED visit (days)	6 months	time until the first ED visit post-discharge
time to 1st readmission (days)	6 months	time until the first readmission post-discharge

Trial Locations

Locations (1)

Vanderbilt Univeristy Medical Center; 🇺🇸 Nashville, Tennessee, United States